Hysingla er and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Hysingla er (hydrocodone bitartrate), especially for people who are female, 50-59 old, also take Hydrocodone Bitartrate And Acetaminophen, and have Pain.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Hysingla er. It is created by eHealthMe based on reports of 32,586 people who have side effects when taking Hysingla er from the FDA, and is updated regularly.

What is Hysingla er?

Hysingla er has active ingredients of hydrocodone bitartrate. eHealthMe is studying from 32,586 Hysingla er users. Check the latest studies of Hysingla er.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,753 drugs and 2,913 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

On Jul, 14, 2026

32,586 people reported to have side effects when taking Hysingla er.
Among them, 17 people (0.05%) have Hypersensitivity.

Could Hysingla er cause Hypersensitivity?

Among these 17 people:

What is the gender of people who have Hypersensitivity when taking Hysingla er? *

female: 68.75 %
male: 31.25 %

What is the age of people who have Hypersensitivity when taking Hysingla er? *

What are other drugs people take besides Hysingla er? *

Dhc Plus: 7 people, 41.18%
Palladone: 7 people, 41.18%
Hydrocodone Bitartrate And Acetaminophen: 7 people, 41.18%
Oxycontin: 6 people, 35.29%
Dilaudid: 5 people, 29.41%
Ms Contin: 4 people, 23.53%
Butrans: 4 people, 23.53%
Oxycodone: 4 people, 23.53%
Ryzolt: 4 people, 23.53%
Oxycodone Hydrochloride: 3 people, 17.65%

What are other side effects people have besides Hypersensitivity? *

Drug Dependence: 7 people, 41.18%
Weight Decreased: 5 people, 29.41%
Overdose: 5 people, 29.41%
Suicidal Ideation: 5 people, 29.41%
Erection Problems: 4 people, 23.53%
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 4 people, 23.53%
Liver Disorder (liver diseases): 4 people, 23.53%
Migraine (headache): 4 people, 23.53%
Learning Disability (difficulty in learning): 4 people, 23.53%
Muscle Twitching: 4 people, 23.53%

What are the existing conditions these people have? *

Pain: 8 people, 47.06%
Stress And Anxiety: 1 person, 5.88%
Spinal Pain (pain in spine): 1 person, 5.88%
Neuralgia (pain in one or more nerves): 1 person, 5.88%
Joint Pain: 1 person, 5.88%
Intervertebral Disc Degeneration (spinal disc degeneration): 1 person, 5.88%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.88%
Back Pain: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Hysingla er and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hysingla er:

Hysingla er (32,586 reports)

Hypersensitivity treatments and more:

Hypersensitivity (272,618 reports)

Browse all side effects of Hysingla er:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,753 drugs)

Browse all the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,913 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydrocodone bitartrate (the active ingredients of Hysingla er) and Hysingla er (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.